Fortive Corporation (FTV)

Sector: Technology|Industry: Scientific & Technical Instruments|Market Cap: $26.33B|Employees: 18K


Fortive Corporation is a global provider of essential technologies for connected workflow solutions, operating through three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The company designs, develops, manufactures, and services professional and engineered products, software, and services, leveraging leading brand names and innovative technologies. Fortive has a significant global presence with operations in over 50 countries and a workforce of more than 18,000 employees.

  1. Filings
  2. Company Profile

Business Summary

Fortive Corporation is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. The company's strategic segments include Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. Fortive's businesses design, develop, manufacture, and service professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. The company is headquartered in Everett, Washington, and has a global presence with a workforce of more than 18,000 professionals.

Key Statistics

  • Employees: Over 18,000 (as of December 31, 2023)
  • Geographic Footprint: More than 50 countries
  • Headquarters: Everett, WA
  • Founded: 2015
  • Number of locations/facilities: Approximately 60 significant facilities
  • Revenue: $6.065 billion (FY2023)
  • Key Subsidiaries/Brands: ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, SERVICECHANNEL, ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, TEKTRONIX, ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD.

Leadership

  • CEO: James A. Lico
  • CFO: Charles E. McLaughlin
  • Other Key Executives: Tamara S. Newcombe (President and CEO of Precision Technologies and Advanced Healthcare Solutions), Jonathan L. Schwarz (Senior Vice President - Corporate Development), Edward R. Simmons (Senior Vice President - Strategy), Olumide Soroye (President and CEO of Intelligent Operating Solutions), Peter C. Underwood (Senior Vice President - General Counsel), Stacey A. Walker (Senior Vice President - Human Resources)

Key Financial Metrics

  • Annual Revenue: $6.065 billion (FY2023)
  • Net Income: $865.8 million (FY2023)
  • Total Assets: $16.911 billion (as of December 31, 2023)
  • Employees: Over 18,000 (as of December 31, 2023)
  • Key Financial Highlights: Year-over-year sales increased 4.1%, primarily due to an increase in sales from existing businesses which increased year-over-year by 4.8% comprised of favorable pricing of 4.5% and increased volume of 0.3%.

Products and Services

Fortive provides essential technologies for connected workflow solutions.

  • Intelligent Operating Solutions: Advanced instrumentation, software, and services for electrical test & measurement, facility and asset lifecycle software, and connected worker safety and compliance solutions.
  • Precision Technologies: Electrical test & measurement, sensing, and material technologies for various industries including industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, and semiconductor.
  • Advanced Healthcare Solutions: Instrument sterilization solutions, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions.

Key Business Segments

Fortive operates through three segments:

  • Intelligent Operating Solutions: Provides advanced instrumentation, software, and services.
  • Precision Technologies: Offers electrical test & measurement, sensing, and material technologies.
  • Advanced Healthcare Solutions: Supplies critical workflow solutions for healthcare providers.

Sales by segment (FY2023): Intelligent Operating Solutions: $2.612 billion, Precision Technologies: $2.132 billion, Advanced Healthcare Solutions: $1.320 billion.

Business Strategy

Fortive's strategy focuses on delivering essential technology for the people who accelerate progress. Key strategic initiatives include:

  • Focusing on relentless execution through the Fortive Business System (FBS).
  • Investing in new product development and commercialization.
  • Driving growth through strategic acquisitions.
  • Incorporating new technology enablers like AI and machine learning.
  • Promoting a culture of continuous improvement.

Industry Context

Fortive operates in highly competitive markets, encountering a wide variety of competitors. The company believes that it has a market leadership position in most of the markets it serves. Key competitive factors include price, quality, performance, delivery speed, applications expertise, distribution channel access, service and support, technology and innovation, breadth of product, service and software offerings, and brand name recognition.

Risk Factors

  • Market Risks: Conditions in the global economy, the markets we serve, and the financial markets and banking systems may adversely affect our business and financial statements. Intense competition and pricing pressures may decrease demand and market share.
  • Operational Risks: Inability to adjust manufacturing capacity, supply chain management, or purchases to reflect changes in market conditions, customer demand, and supply chain disruptions. Reliance on sole or limited sources of supply could cause production interruptions, delays, and inefficiencies.
  • Financial Risks: Fluctuations in the cost and availability of commodities or components. Foreign currency exchange rates may adversely affect our financial statements.
  • Regulatory Risks: Changes in industry standards and governmental regulations may reduce demand or increase expenses. Exposure to extensive regulation, including healthcare regulations, could adversely affect our financial statements.

Last Updated

2024-02-27

(Generated from latest 10-K filing)